Published in Adv Cancer Res on January 01, 1978
Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A (1980) 1.61
Translation of bovine leukemia virus virion RNAs in heterologous protein-synthesizing systems. J Virol (1979) 1.60
Integration of bovine leukemia virus DNA in the bovine genome. Proc Natl Acad Sci U S A (1979) 1.23
Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV. Viruses (2011) 1.14
The SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions. J Virol (2000) 0.97
Sporadic bovine leukosis: a description of eight calves received at Animal Diseases Research Institute from 1974-1980. Can Vet J (1980) 0.87
Reduced cell turnover in bovine leukemia virus-infected, persistently lymphocytotic cattle. J Virol (2003) 0.85
Embryo transfer: a discussion on its potential for infectious disease control based on a review of studies on infection of gametes and early embryos by various agents. Can Vet J (1980) 0.82
Leukaemia 'firsts' in cancer research and treatment. Nat Rev Cancer (2016) 0.79
Purified bovine plasma blocking factor decreases Bovine leukemia virus p24 expression while increasing protein synthesis and transcriptional activity of peripheral blood mononuclear cells in short-term culture. Can J Vet Res (2005) 0.78
The role of virus dose in experimental bovine leukemia virus infection in sheep. Can J Vet Res (1988) 0.76
The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature (1987) 7.06
Purification of the DNA polymerase of avian myeloblastosis virus. Biochim Biophys Acta (1971) 6.64
Characterization of the products of DNA-directed DNA polymerases in oncogenic RNA viruses. Nature (1970) 5.23
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
DNA-directed DNA polymerase activity in oncogenic RNA viruses. Nature (1970) 4.81
A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science (1997) 4.29
Identification and classification of bacterial plasmids. Microbiol Rev (1988) 4.16
Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science (1986) 4.04
Synthetic DNA-RNA hybrids and RNA-RNA duplexes as templates for the polymerases of the oncogenic RNA viruses. Nature (1970) 3.98
The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J (1989) 3.50
HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J (1999) 3.10
Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J (1993) 2.91
The gag and pol genes of bovine leukemia virus: nucleotide sequence and analysis. Virology (1985) 2.53
Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics (1996) 2.34
Cooperative binding of Ets-1 and core binding factor to DNA. Mol Cell Biol (1994) 2.27
[Isolation of messenger RNA from rabbit reticulocytes]. Biochim Biophys Acta (1965) 2.25
DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol (1994) 2.18
A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Mol Endocrinol (1989) 2.16
The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature (1988) 2.16
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Homologous tyrosine phosphorylation sites in transformation-specific gene products of distinct avian sarcoma viruses. Nature (1981) 2.11
Role of the polyadenylate segment in the translation of globin messenger RNA in Xenopus oocytes. Proc Natl Acad Sci U S A (1974) 2.05
Tyrosine-specific protein kinase activity associated with p105 of avian sarcoma virus PRCII. Virology (1981) 2.03
The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1. EMBO J (1990) 2.03
Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc Natl Acad Sci U S A (1982) 2.02
Bovine leukemia virus: an exogenous RNA oncogenic virus. Proc Natl Acad Sci U S A (1976) 2.01
Identification in chickens of an evolutionarily conserved cellular ets-2 gene (c-ets-2) encoding nuclear proteins related to the products of the c-ets proto-oncogene. EMBO J (1988) 1.99
The nucleotide sequence of the env gene and post-env region of bovine leukemia virus. Virology (1984) 1.98
Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein. Proc Natl Acad Sci U S A (1986) 1.89
Identification of nucleotide preferences in DNA sequences recognised specifically by c-Ets-1 protein. Nucleic Acids Res (1992) 1.82
Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol Cell Biol (1992) 1.81
Class IIa histone deacetylases: regulating the regulators. Oncogene (2007) 1.78
Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. Mol Endocrinol (1992) 1.71
In vivo infection of sheep by bovine leukemia virus mutants. J Virol (1993) 1.69
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A (1998) 1.68
Electron microscopical studies on the localisation of the different components of cell walls of gram-negative bacteria. Folia Microbiol (Praha) (1967) 1.68
Sensitivity of clinical and behavioural tests of spatial neglect after right hemisphere stroke. J Neurol Neurosurg Psychiatry (2002) 1.67
DNA polymerase activities in varions of visna virus, a causative agent of a "slow" neurological disease. Proc Natl Acad Sci U S A (1971) 1.67
Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells. Science (1985) 1.67
Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro. Mol Cell Biol (1989) 1.67
Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51. J Virol Methods (1989) 1.66
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol (1999) 1.65
Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A (1980) 1.61
A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J (1997) 1.60
Translation of bovine leukemia virus virion RNAs in heterologous protein-synthesizing systems. J Virol (1979) 1.60
The chemical composition of idiopathic nonarteriosclerotic cerebral calcifications. Neurology (1975) 1.59
Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species. J Virol (1981) 1.58
Mitogenic stimulation of thymocytes results in the calcium-dependent phosphorylation of c-ets-1 proteins. EMBO J (1988) 1.58
Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor. J Virol (1993) 1.58
C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci U S A (1998) 1.57
Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1. EMBO J (1993) 1.57
GATA and Ets cis-acting sequences mediate megakaryocyte-specific expression. Mol Cell Biol (1993) 1.57
An immunophilin that binds M(r) 90,000 heat shock protein: main structural features of a mammalian p59 protein. Proc Natl Acad Sci U S A (1992) 1.56
Characterization of the messenger ribonucleoprotein released from reticulocyte polyribosomes by EDTA treatment. Eur J Biochem (1971) 1.56
Genomic integration of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk Res (1980) 1.53
Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. Blood (2000) 1.52
Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. Virology (1993) 1.52
Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes. Proc Natl Acad Sci U S A (1975) 1.51
The bovine leukemia virus p34 is a transactivator protein. EMBO J (1987) 1.48
Bone biomechanical properties in LRP5 mutant mice. Bone (2004) 1.47
Expression of the v-erbA oncogene in chicken embryo fibroblasts stimulates their proliferation in vitro and enhances tumor growth in vivo. Cell (1987) 1.46
A phorbol ester response element within the human T-cell receptor beta-chain enhancer. Proc Natl Acad Sci U S A (1992) 1.44
Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J (1990) 1.44
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci U S A (2000) 1.42
The anatomy of aphasia revisited. Neurology (2000) 1.41
Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1. Oncogene (1994) 1.40
Readenylation of polyadenylate-free globin messenger RNA restores its stability in vivo. Eur J Biochem (1975) 1.40